Patents by Inventor Carlos Gonzalez-Hernandez
Carlos Gonzalez-Hernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10369211Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.Type: GrantFiled: July 28, 2017Date of Patent: August 6, 2019Inventors: Mauricio Realpe-Quintero, Paulino Carlos Gonzalez-Hernandez, Eric Vaughn
-
Publication number: 20170348413Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.Type: ApplicationFiled: July 28, 2017Publication date: December 7, 2017Inventors: Mauricio REALPE-QUINTERO, Paulino Carlos GONZALEZ-HERNANDEZ, Eric VAUGHN
-
Patent number: 9375469Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.Type: GrantFiled: October 23, 2013Date of Patent: June 28, 2016Assignee: Boehringer Ingelheim Vetmedica, Inc.Inventors: Eric Martin Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Daemmgen
-
Publication number: 20140199337Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.Type: ApplicationFiled: August 15, 2012Publication date: July 17, 2014Applicants: BOEHRINGER INGELHEIM VETMEDICA S.A. DE C.V., BOEHRINGER INGELHEIM VETMEDICA GMBHInventors: Mauricio Realpe-Quintero, Paulino Carlos Gonzalez-Hernandez, Eric Vaughn
-
Publication number: 20140050755Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.Type: ApplicationFiled: October 23, 2013Publication date: February 20, 2014Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.Inventors: Eric Martin VAUGHN, Paulino Carlos GONZALEZ-HERNANDEZ, Juergen DAEMMGEN
-
Patent number: 8592558Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.Type: GrantFiled: May 21, 2012Date of Patent: November 26, 2013Assignee: Boehringer Ingelheim Vetmedica, Inc.Inventors: Eric M. Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Daemmgen
-
Publication number: 20120231027Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.Type: ApplicationFiled: May 21, 2012Publication date: September 13, 2012Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.Inventors: Eric VAUGHN, Paulino Carlos GONZALEZ-HERNANDEZ, Juergen DAEMMGEN
-
Patent number: 8202967Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.Type: GrantFiled: October 24, 2007Date of Patent: June 19, 2012Assignee: Boehringer Ingelheim Vetmedica, Inc.Inventors: Eric Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Däemmgen
-
Publication number: 20110212132Abstract: The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Gallibacterium. The invention provides said Gallibacterium bacteria, vaccine comprising inactivated Gallibacterium, and a method of immunizing to prevent disease in poultry.Type: ApplicationFiled: May 9, 2011Publication date: September 1, 2011Applicant: BOEHRINGER INGELHEIM VETMEDICA S.A. DE C.V.Inventors: Raul CAMPOGARRIDO, Carlos GONZALEZ-HERNANDEZ, Vaithianathan SIVANANDAN, Maria Elena VAZQUEZ
-
Patent number: 7964197Abstract: The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Gallibacterium. The invention provides said Gallibacterium bacteria, vaccine comprising inactivated Gallibacterium, and a method of immunizing to prevent disease in poultry.Type: GrantFiled: August 26, 2009Date of Patent: June 21, 2011Assignee: Boeringer Ingelheim Vetmedica S.A. de C.VInventors: Raul Campogarrido, Carlos Gonzalez-Hernandez, Vaithianathan Sivanandan, Maria Elena Vazquez
-
Patent number: 7794735Abstract: The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Gallibacterium. The invention provides said Gallibacterium bacteria, vaccine comprising inactivated Gallibacterium, and a method of immunizing to prevent disease in poultry.Type: GrantFiled: February 25, 2009Date of Patent: September 14, 2010Assignee: Boehringer Ingelheim Vetmedica S.A. DE C.V.Inventors: Raul Campogarrido, Carlos Gonzalez-Hernandez, Vaithianathan Sivanandan, Maria Elena Vazquez
-
Publication number: 20100104594Abstract: The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Gallibacterium. The invention provides said Gallibacterium bacteria, vaccine comprising inactivated Gallibacterium, and a method of immunizing to prevent disease in poultry.Type: ApplicationFiled: August 26, 2009Publication date: April 29, 2010Applicant: BOEHRINGER INGELHEIM VETMEDICA, S.A. DE C.V.Inventors: Raul Campogarrido, Carlos Gonzalez-Hernandez, Vaithianathan Sivanandan, Maria Elena Vazquez
-
Publication number: 20090181055Abstract: The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Gallibacterium. The invention provides said Gallibacterium bacteria, vaccine comprising inactivated Gallibacterium, and a method of immunizing to prevent disease in poultry.Type: ApplicationFiled: February 25, 2009Publication date: July 16, 2009Applicant: BOEHRINGER INGELHEIM VETMEDICA, S.A. DE C.V.Inventors: Raul Campogarrido, Carlos Gonzalez-Hernandez, Vaithianathan Sivanandan, Maria Elena Vazquez
-
Patent number: 7521060Abstract: The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Gallibacterium. The invention provides said Gallibacterium bacteria, vaccine comprising inactivated Gallibacterium, and a method of immunizing to prevent disease in poultry.Type: GrantFiled: October 24, 2002Date of Patent: April 21, 2009Assignee: Boehringer Ingelheim Vetmedica S.A. de C.V.Inventors: Raul Campogarrido, Carlos Gonzalez-Hernandez, Vaithianathan Sivanandan, Maria Elena Vazquez
-
Publication number: 20080193471Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.Type: ApplicationFiled: October 24, 2007Publication date: August 14, 2008Applicant: Boehringer Ingelheim Vetmedica, Inc.Inventors: Eric Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Daemmgen
-
Publication number: 20030175835Abstract: The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Pasteurella trehalosi and/or Mannheimia haemolytica. The invention provides said Pasteurella trehalosi and/or Mannheimia haemolytica bacteria, vaccine comprising inactivated Pasteurella trehalosi and/or Mannheimia haemolytica, and a method of immunizing to prevent disease in poultry.Type: ApplicationFiled: October 24, 2002Publication date: September 18, 2003Applicant: Boehringer Ingelheim Vetmedica S.A. de C.V.Inventors: Raul Campogarrido, Carlos Gonzalez-Hernandez, Vaithianathan Sivanandan, Maria Elena Vazquez